 | • レポートコード：GIR-2104Z00981 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、抗血友病因子薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。抗血友病因子薬の種類別市場規模（250 IU、500 IU、1000 IU、1500 IU、2000 IU、3000 IU、4000 IU、その他）、用途別市場規模（成人、小児）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・抗血友病因子薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bayer、Takeda、Novo Nordisk、Pfizer、Grifols、CSL Behring、Sanofi、Cigna、Octapharma、GC Pharma、Hualan Biological Engineering、Shanghai RAAS blood products ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：250 IU、500 IU、1000 IU、1500 IU、2000 IU、3000 IU、4000 IU、その他 ・用途別分析2016年-2026年：成人、小児 ・抗血友病因子薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・抗血友病因子薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・抗血友病因子薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・抗血友病因子薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・抗血友病因子薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Antihemophilic Factor Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Antihemophilic Factor Drug size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Antihemophilic Factor Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Antihemophilic Factor Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
250 IU
500 IU
1000 IU
1500 IU
2000 IU
3000 IU
4000 IU
Other potencies
Market segment by Application can be divided into
Adult
Pediatric
The key market players for global Antihemophilic Factor Drug market are listed below:
Bayer
Takeda
Novo Nordisk
Pfizer
Grifols
CSL Behring
Sanofi
Cigna
Octapharma
GC Pharma
Hualan Biological Engineering
Shanghai RAAS blood products
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Antihemophilic Factor Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antihemophilic Factor Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 250 IU
1.2.3 500 IU
1.2.4 1000 IU
1.2.5 1500 IU
1.2.6 2000 IU
1.2.7 3000 IU
1.2.8 4000 IU
1.2.9 Other potencies
1.3 Market Analysis by Application
1.3.1 Overview: Global Antihemophilic Factor Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Adult
1.3.3 Pediatric
1.4 Global Antihemophilic Factor Drug Market Size & Forecast
1.4.1 Global Antihemophilic Factor Drug Sales in Value (2016-2026))
1.4.2 Global Antihemophilic Factor Drug Sales in Volume (2016-2026)
1.4.3 Global Antihemophilic Factor Drug Price by Type (2016-2026) & (USD/Unit)
1.5 Global Antihemophilic Factor Drug Production Capacity Analysis
1.5.1 Global Antihemophilic Factor Drug Total Production Capacity (2016-2026)
1.5.2 Global Antihemophilic Factor Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Antihemophilic Factor Drug Market Drivers
1.6.2 Antihemophilic Factor Drug Market Restraints
1.6.3 Antihemophilic Factor Drug Trends Analysis
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Antihemophilic Factor Drug Product and Services
2.1.4 Bayer Antihemophilic Factor Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business
2.2.3 Takeda Antihemophilic Factor Drug Product and Services
2.2.4 Takeda Antihemophilic Factor Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Novo Nordisk
2.3.1 Novo Nordisk Details
2.3.2 Novo Nordisk Major Business
2.3.3 Novo Nordisk Antihemophilic Factor Drug Product and Services
2.3.4 Novo Nordisk Antihemophilic Factor Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Antihemophilic Factor Drug Product and Services
2.4.4 Pfizer Antihemophilic Factor Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Grifols
2.5.1 Grifols Details
2.5.2 Grifols Major Business
2.5.3 Grifols Antihemophilic Factor Drug Product and Services
2.5.4 Grifols Antihemophilic Factor Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 CSL Behring
2.6.1 CSL Behring Details
2.6.2 CSL Behring Major Business
2.6.3 CSL Behring Antihemophilic Factor Drug Product and Services
2.6.4 CSL Behring Antihemophilic Factor Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Antihemophilic Factor Drug Product and Services
2.7.4 Sanofi Antihemophilic Factor Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Cigna
2.8.1 Cigna Details
2.8.2 Cigna Major Business
2.8.3 Cigna Antihemophilic Factor Drug Product and Services
2.8.4 Cigna Antihemophilic Factor Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Octapharma
2.9.1 Octapharma Details
2.9.2 Octapharma Major Business
2.9.3 Octapharma Antihemophilic Factor Drug Product and Services
2.9.4 Octapharma Antihemophilic Factor Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 GC Pharma
2.10.1 GC Pharma Details
2.10.2 GC Pharma Major Business
2.10.3 GC Pharma Antihemophilic Factor Drug Product and Services
2.10.4 GC Pharma Antihemophilic Factor Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Hualan Biological Engineering
2.11.1 Hualan Biological Engineering Details
2.11.2 Hualan Biological Engineering Major Business
2.11.3 Hualan Biological Engineering Antihemophilic Factor Drug Product and Services
2.11.4 Hualan Biological Engineering Antihemophilic Factor Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Shanghai RAAS blood products
2.12.1 Shanghai RAAS blood products Details
2.12.2 Shanghai RAAS blood products Major Business
2.12.3 Shanghai RAAS blood products Antihemophilic Factor Drug Product and Services
2.12.4 Shanghai RAAS blood products Antihemophilic Factor Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Antihemophilic Factor Drug Sales by Manufacturer
3.1 Global Antihemophilic Factor Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Antihemophilic Factor Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Antihemophilic Factor Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Antihemophilic Factor Drug Manufacturer Market Share
3.4.2 Top 6 Antihemophilic Factor Drug Manufacturer Market Share
3.5 Global Antihemophilic Factor Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Antihemophilic Factor Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Antihemophilic Factor Drug Market Size by Region
4.1.1 Global Antihemophilic Factor Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Antihemophilic Factor Drug Revenue by Region (2016-2026)
4.2 North America Antihemophilic Factor Drug Revenue (2016-2026)
4.3 Europe Antihemophilic Factor Drug Revenue (2016-2026)
4.4 Asia-Pacific Antihemophilic Factor Drug Revenue (2016-2026)
4.5 South America Antihemophilic Factor Drug Revenue (2016-2026)
4.6 Middle East and Africa Antihemophilic Factor Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Antihemophilic Factor Drug Sales in Volume by Type (2016-2026)
5.2 Global Antihemophilic Factor Drug Revenue by Type (2016-2026)
5.3 Global Antihemophilic Factor Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Antihemophilic Factor Drug Sales in Volume by Application (2016-2026)
6.2 Global Antihemophilic Factor Drug Revenue by Application (2016-2026)
6.3 Global Antihemophilic Factor Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Antihemophilic Factor Drug Sales by Type (2016-2026)
7.2 North America Antihemophilic Factor Drug Sales by Application (2016-2026)
7.3 North America Antihemophilic Factor Drug Market Size by Country
7.3.1 North America Antihemophilic Factor Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Antihemophilic Factor Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Antihemophilic Factor Drug Sales by Type (2016-2026)
8.2 Europe Antihemophilic Factor Drug Sales by Application (2016-2026)
8.3 Europe Antihemophilic Factor Drug Market Size by Country
8.3.1 Europe Antihemophilic Factor Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Antihemophilic Factor Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Antihemophilic Factor Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Antihemophilic Factor Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Antihemophilic Factor Drug Market Size by Region
9.3.1 Asia-Pacific Antihemophilic Factor Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Antihemophilic Factor Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Antihemophilic Factor Drug Sales by Type (2016-2026)
10.2 South America Antihemophilic Factor Drug Sales by Application (2016-2026)
10.3 South America Antihemophilic Factor Drug Market Size by Country
10.3.1 South America Antihemophilic Factor Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Antihemophilic Factor Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Antihemophilic Factor Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Antihemophilic Factor Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Antihemophilic Factor Drug Market Size by Country
11.3.1 Middle East & Africa Antihemophilic Factor Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Antihemophilic Factor Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Antihemophilic Factor Drug Typical Distributors
12.3 Antihemophilic Factor Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Antihemophilic Factor Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Antihemophilic Factor Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer Antihemophilic Factor Drug Product and Services
Table 6. Bayer Antihemophilic Factor Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Takeda Basic Information, Manufacturing Base and Competitors
Table 8. Takeda Major Business
Table 9. Takeda Antihemophilic Factor Drug Product and Services
Table 10. Takeda Antihemophilic Factor Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 12. Novo Nordisk Major Business
Table 13. Novo Nordisk Antihemophilic Factor Drug Product and Services
Table 14. Novo Nordisk Antihemophilic Factor Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Pfizer Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer Antihemophilic Factor Drug Product and Services
Table 18. Pfizer Antihemophilic Factor Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Grifols Basic Information, Manufacturing Base and Competitors
Table 20. Grifols Major Business
Table 21. Grifols Antihemophilic Factor Drug Product and Services
Table 22. Grifols Antihemophilic Factor Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 24. CSL Behring Major Business
Table 25. CSL Behring Antihemophilic Factor Drug Product and Services
Table 26. CSL Behring Antihemophilic Factor Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Sanofi Basic Information, Manufacturing Base and Competitors
Table 28. Sanofi Major Business
Table 29. Sanofi Antihemophilic Factor Drug Product and Services
Table 30. Sanofi Antihemophilic Factor Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Cigna Basic Information, Manufacturing Base and Competitors
Table 32. Cigna Major Business
Table 33. Cigna Antihemophilic Factor Drug Product and Services
Table 34. Cigna Antihemophilic Factor Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Octapharma Basic Information, Manufacturing Base and Competitors
Table 36. Octapharma Major Business
Table 37. Octapharma Antihemophilic Factor Drug Product and Services
Table 38. Octapharma Antihemophilic Factor Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. GC Pharma Basic Information, Manufacturing Base and Competitors
Table 40. GC Pharma Major Business
Table 41. GC Pharma Antihemophilic Factor Drug Product and Services
Table 42. GC Pharma Antihemophilic Factor Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Hualan Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 44. Hualan Biological Engineering Major Business
Table 45. Hualan Biological Engineering Antihemophilic Factor Drug Product and Services
Table 46. Hualan Biological Engineering Antihemophilic Factor Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Shanghai RAAS blood products Basic Information, Manufacturing Base and Competitors
Table 48. Shanghai RAAS blood products Major Business
Table 49. Shanghai RAAS blood products Antihemophilic Factor Drug Product and Services
Table 50. Shanghai RAAS blood products Antihemophilic Factor Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Global Antihemophilic Factor Drug Sales by Manufacturer (2019-2021e) & (K Units)
Table 52. Global Antihemophilic Factor Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 53. Market Position of Manufacturers in Antihemophilic Factor Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 54. Global Antihemophilic Factor Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and Antihemophilic Factor Drug Production Site of Key Manufacturer
Table 56. Global Antihemophilic Factor Drug Sales by Region (2016-2021e) & (K Units)
Table 57. Global Antihemophilic Factor Drug Sales by Region (2021-2026) & (K Units)
Table 58. Global Antihemophilic Factor Drug Revenue by Region (2016-2021e) & (USD Million)
Table 59. Global Antihemophilic Factor Drug Revenue by Region (2021-2026) & (USD Million)
Table 60. Global Antihemophilic Factor Drug Sales by Type (2016-2021e) & (K Units)
Table 61. Global Antihemophilic Factor Drug Sales by Type (2021-2026) & (K Units)
Table 62. Global Antihemophilic Factor Drug Revenue by Type (2016-2021e) & (USD Million)
Table 63. Global Antihemophilic Factor Drug Revenue by Type (2021-2026) & (USD Million)
Table 64. Global Antihemophilic Factor Drug Price by Type (2016-2021e) & (USD/Unit)
Table 65. Global Antihemophilic Factor Drug Price by Type (2021-2026) & (USD/Unit)
Table 66. Global Antihemophilic Factor Drug Sales by Application (2016-2021e) & (K Units)
Table 67. Global Antihemophilic Factor Drug Sales by Application (2021-2026) & (K Units)
Table 68. Global Antihemophilic Factor Drug Revenue by Application (2016-2021e) & (USD Million)
Table 69. Global Antihemophilic Factor Drug Revenue by Application (2021-2026) & (USD Million)
Table 70. Global Antihemophilic Factor Drug Price by Application (2016-2021e) & (USD/Unit)
Table 71. Global Antihemophilic Factor Drug Price by Application (2021-2026) & (USD/Unit)
Table 72. North America Antihemophilic Factor Drug Sales by Country (2016-2021e) & (K Units)
Table 73. North America Antihemophilic Factor Drug Sales by Country (2021-2026) & (K Units)
Table 74. North America Antihemophilic Factor Drug Revenue by Country (2016-2021e) & (USD Million)
Table 75. North America Antihemophilic Factor Drug Revenue by Country (2021-2026) & (USD Million)
Table 76. North America Antihemophilic Factor Drug Sales by Type (2016-2021e) & (K Units)
Table 77. North America Antihemophilic Factor Drug Sales by Type (2021-2026) & (K Units)
Table 78. North America Antihemophilic Factor Drug Sales by Application (2016-2021e) & (K Units)
Table 79. North America Antihemophilic Factor Drug Sales by Application (2021-2026) & (K Units)
Table 80. Europe Antihemophilic Factor Drug Sales by Country (2016-2021e) & (K Units)
Table 81. Europe Antihemophilic Factor Drug Sales by Country (2021-2026) & (K Units)
Table 82. Europe Antihemophilic Factor Drug Revenue by Country (2016-2021e) & (USD Million)
Table 83. Europe Antihemophilic Factor Drug Revenue by Country (2021-2026) & (USD Million)
Table 84. Europe Antihemophilic Factor Drug Sales by Type (2016-2021e) & (K Units)
Table 85. Europe Antihemophilic Factor Drug Sales by Type (2021-2026) & (K Units)
Table 86. Europe Antihemophilic Factor Drug Sales by Application (2016-2021e) & (K Units)
Table 87. Europe Antihemophilic Factor Drug Sales by Application (2021-2026) & (K Units)
Table 88. Asia-Pacific Antihemophilic Factor Drug Sales by Region (2016-2021e) & (K Units)
Table 89. Asia-Pacific Antihemophilic Factor Drug Sales by Region (2021-2026) & (K Units)
Table 90. Asia-Pacific Antihemophilic Factor Drug Revenue by Region (2016-2021e) & (USD Million)
Table 91. Asia-Pacific Antihemophilic Factor Drug Revenue by Region (2021-2026) & (USD Million)
Table 92. Asia-Pacific Antihemophilic Factor Drug Sales by Type (2016-2021e) & (K Units)
Table 93. Asia-Pacific Antihemophilic Factor Drug Sales by Type (2021-2026) & (K Units)
Table 94. Asia-Pacific Antihemophilic Factor Drug Sales by Application (2016-2021e) & (K Units)
Table 95. Asia-Pacific Antihemophilic Factor Drug Sales by Application (2021-2026) & (K Units)
Table 96. South America Antihemophilic Factor Drug Sales by Country (2016-2021e) & (K Units)
Table 97. South America Antihemophilic Factor Drug Sales by Country (2021-2026) & (K Units)
Table 98. South America Antihemophilic Factor Drug Revenue by Country (2016-2021e) & (USD Million)
Table 99. South America Antihemophilic Factor Drug Revenue by Country (2021-2026) & (USD Million)
Table 100. South America Antihemophilic Factor Drug Sales by Type (2016-2021e) & (K Units)
Table 101. South America Antihemophilic Factor Drug Sales by Type (2021-2026) & (K Units)
Table 102. South America Antihemophilic Factor Drug Sales by Application (2016-2021e) & (K Units)
Table 103. South America Antihemophilic Factor Drug Sales by Application (2021-2026) & (K Units)
Table 104. Middle East & Africa Antihemophilic Factor Drug Sales by Country (2016-2021e) & (K Units)
Table 105. Middle East & Africa Antihemophilic Factor Drug Sales by Country (2021-2026) & (K Units)
Table 106. Middle East & Africa Antihemophilic Factor Drug Revenue by Country (2016-2021e) & (USD Million)
Table 107. Middle East & Africa Antihemophilic Factor Drug Revenue by Country (2021-2026) & (USD Million)
Table 108. Middle East & Africa Antihemophilic Factor Drug Sales by Type (2016-2021e) & (K Units)
Table 109. Middle East & Africa Antihemophilic Factor Drug Sales by Type (2021-2026) & (K Units)
Table 110. Middle East & Africa Antihemophilic Factor Drug Sales by Application (2016-2021e) & (K Units)
Table 111. Middle East & Africa Antihemophilic Factor Drug Sales by Application (2021-2026) & (K Units)
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Antihemophilic Factor Drug Typical Distributors
Table 115. Antihemophilic Factor Drug Typical Customers
List of Figures
Figure 1. Antihemophilic Factor Drug Picture
Figure 2. Global Antihemophilic Factor Drug Sales Market Share by Type in 2020
Figure 3. 250 IU
Figure 4. 500 IU
Figure 5. 1000 IU
Figure 6. 1500 IU
Figure 7. 2000 IU
Figure 8. 3000 IU
Figure 9. 4000 IU
Figure 10. Other potencies
Figure 11. Global Antihemophilic Factor Drug Sales Market Share by Application in 2020
Figure 12. Adult
Figure 13. Pediatric
Figure 14. Global Antihemophilic Factor Drug Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 15. Global Antihemophilic Factor Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. United States Antihemophilic Factor Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Canada Antihemophilic Factor Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Mexico Antihemophilic Factor Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Germany Antihemophilic Factor Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. France Antihemophilic Factor Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. United Kingdom Antihemophilic Factor Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Russia Antihemophilic Factor Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Italy Antihemophilic Factor Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. China Antihemophilic Factor Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Japan Antihemophilic Factor Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Korea Antihemophilic Factor Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. India Antihemophilic Factor Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Southeast Asia Antihemophilic Factor Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Australia Antihemophilic Factor Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Brazil Antihemophilic Factor Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Egypt Antihemophilic Factor Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Saudi Arabia Antihemophilic Factor Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. South Africa Antihemophilic Factor Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Turkey Antihemophilic Factor Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Global Antihemophilic Factor Drug Sales (2016-2026) & (K Units)
Figure 36. Global Antihemophilic Factor Drug Production Capacity (2016-2026) & (K Units)
Figure 37. Global Antihemophilic Factor Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 38. Antihemophilic Factor Drug Market Drivers
Figure 39. Antihemophilic Factor Drug Market Restraints
Figure 40. Antihemophilic Factor Drug Market Trends
Figure 41. Global Antihemophilic Factor Drug Sales Market Share by Manufacturer in 2020
Figure 42. Global Antihemophilic Factor Drug Revenue Market Share by Manufacturer in 2020
Figure 43. Antihemophilic Factor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 44. Top 3 Antihemophilic Factor Drug Manufacturer (Revenue) Market Share in 2020
Figure 45. Top 6 Antihemophilic Factor Drug Manufacturer (Revenue) Market Share in 2020
Figure 46. Global Antihemophilic Factor Drug Sales Market Share by Region (2016-2026)
Figure 47. Global Antihemophilic Factor Drug Revenue Market Share by Region (2016-2026)
Figure 48. North America Antihemophilic Factor Drug Revenue (2016-2026) & (USD Million)
Figure 49. Europe Antihemophilic Factor Drug Revenue (2016-2026) & (USD Million)
Figure 50. Asia-Pacific Antihemophilic Factor Drug Revenue (2016-2026) & (USD Million)
Figure 51. South America Antihemophilic Factor Drug Revenue (2016-2026) & (USD Million)
Figure 52. Middle East & Africa Antihemophilic Factor Drug Revenue (2016-2026) & (USD Million)
Figure 53. Global Antihemophilic Factor Drug Sales Market Share by Type (2016-2026)
Figure 54. Global Antihemophilic Factor Drug Revenue Market Share by Type (2016-2026)
Figure 55. Global Antihemophilic Factor Drug Price by Type (2016-2026) & (USD/Unit)
Figure 56. Global Antihemophilic Factor Drug Sales Market Share by Application (2016-2026)
Figure 57. Global Antihemophilic Factor Drug Revenue Market Share by Application (2016-2026)
Figure 58. Global Antihemophilic Factor Drug Price by Application (2016-2026) & (USD/Unit)
Figure 59. North America Antihemophilic Factor Drug Sales Market Share by Country (2016-2026)
Figure 60. North America Antihemophilic Factor Drug Revenue Market Share by Country (2016-2026)
Figure 61. North America Antihemophilic Factor Drug Sales Market Share by Type (2016-2026)
Figure 62. North America Antihemophilic Factor Drug Sales Market Share by Application (2016-2026)
Figure 63. Europe Antihemophilic Factor Drug Sales Market Share by Country (2016-2026)
Figure 64. Europe Antihemophilic Factor Drug Revenue Market Share by Country (2016-2026)
Figure 65. Europe Antihemophilic Factor Drug Sales Market Share by Type (2016-2026)
Figure 66. Europe Antihemophilic Factor Drug Sales Market Share by Application (2016-2026)
Figure 67. Asia-Pacific Antihemophilic Factor Drug Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Antihemophilic Factor Drug Revenue Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Antihemophilic Factor Drug Sales Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Antihemophilic Factor Drug Sales Market Share by Application (2016-2026)
Figure 71. South America Antihemophilic Factor Drug Sales Market Share by Country (2016-2026)
Figure 72. South America Antihemophilic Factor Drug Revenue Market Share by Country (2016-2026)
Figure 73. South America Antihemophilic Factor Drug Sales Market Share by Type (2016-2026)
Figure 74. South America Antihemophilic Factor Drug Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Antihemophilic Factor Drug Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Antihemophilic Factor Drug Revenue Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Antihemophilic Factor Drug Sales Market Share by Type (2016-2026)
Figure 78. Middle East & Africa Antihemophilic Factor Drug Sales Market Share by Application (2016-2026)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
世界の抗血友病因子（AHF）・フォンウィルブランド因子（VWF）複合体市場規模・現状・予測（2021年-2027年） Antihemophilic and von Willebrand factor complex is a combination medicine used to treat or prevent bleeding episodes in people with von Willebrand disease. Antihemophilic and von Willebrand factor complex is also used to treat or prevent bleeding episodes in people with hemophilia A. Market Analysi…- 世界の抗血友病因子（組換え）市場規模・現状・予測（2021年-2027年） Antihemophilic factor is a naturally occurring protein in the blood that helps blood to clot. Market Analysis and Insights: Global Antihemophilic Factor (Recombinant) Market The global Antihemophilic Factor (Recombinant) market size is projected to reach US$ XX million by 2027, from US$ XX million i…
- 世界の第IX因子欠乏症治療市場規模・現状・予測（2021年-2027年） Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B. In this market study, analysts have estimated the prophylaxis segment to dominate the factor IX deficiency treatment market dur…
- 世界の凝固因子市場規模・現状・予測（2021年-2027年） Coagulation factors are various protein components involved in blood coagulation. Its physiological function is to be activated when blood vessels bleed, stick to platelets and plug leaks in blood vessels. Market Analysis and Insights: Global Clotting Factor Market The global Clotting Factor market …
- 世界の第IX因子欠乏症治療市場 2021：企業別、地域別、種類・用途別 The Factor IX Deficiency Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …